PILMAN » Access http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 Why India Encourages Healthcare Innovation – but Refuses to Copy the Western IP Model http://www.tapanray.in/why-india-encourages-healthcare-innovation-but-refuses-to-copy-the-western-ip-model/?utm_source=rss&utm_medium=rss&utm_campaign=why-india-encourages-healthcare-innovation-but-refuses-to-copy-the-western-ip-model http://www.tapanray.in/why-india-encourages-healthcare-innovation-but-refuses-to-copy-the-western-ip-model/#comments Sun, 21 Dec 2025 10:43:57 +0000 Tapan Ray http://www.tapanray.in/?p=11013 Continue reading →]]> http://www.tapanray.in/why-india-encourages-healthcare-innovation-but-refuses-to-copy-the-western-ip-model/feed/ 0 When Patents Meet Patients: Why India Revoked Novartis’ Vymada Patent http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/?utm_source=rss&utm_medium=rss&utm_campaign=when-patents-meet-patients-why-india-revoked-novartis-vymada-patent http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/#comments Thu, 18 Sep 2025 12:11:29 +0000 Tapan Ray http://www.tapanray.in/?p=10971 Continue reading →]]> http://www.tapanray.in/when-patents-meet-patients-why-india-revoked-novartis-vymada-patent/feed/ 0 Drug Prescription In Generic Names Only, No Branded Generics http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/?utm_source=rss&utm_medium=rss&utm_campaign=drug-prescription-in-generic-names-only-no-branded-generics http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/#comments Sun, 20 Aug 2023 07:24:49 +0000 Tapan Ray http://www.tapanray.in/?p=10812 Continue reading →]]> http://www.tapanray.in/drug-prescription-in-generic-names-only-no-branded-generics/feed/ 0 Meeting India’s Unmet Biologic Drug Needs Some Global Synergy Evident – But Patients Need More http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/?utm_source=rss&utm_medium=rss&utm_campaign=meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/#comments Mon, 17 Jul 2023 00:00:32 +0000 Tapan Ray http://www.tapanray.in/?p=10799 Continue reading →]]> http://www.tapanray.in/meeting-indias-unmet-biologic-drug-needs-some-global-synergy-evident-but-patients-need-more/feed/ 0 Exploiting India’s Weakness For Monopolistic Commercial Gain? http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/?utm_source=rss&utm_medium=rss&utm_campaign=exploiting-indias-weakness-for-monopolistic-commercial-gain http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/#comments Mon, 08 May 2023 00:00:11 +0000 Tapan Ray http://www.tapanray.in/?p=10776 Continue reading →]]> http://www.tapanray.in/exploiting-indias-weakness-for-monopolistic-commercial-gain/feed/ 0 To Reduce Disease Burden India Launches A New Study On Access to Affordable Drugs http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/#comments Mon, 28 Mar 2022 00:00:33 +0000 Tapan Ray http://www.tapanray.in/?p=10678 Continue reading →]]> http://www.tapanray.in/to-reduce-disease-burden-india-launches-a-new-study-on-access-to-affordable-drugs/feed/ 0 Focus On All 3 Areas of Innovation For Affordable Access To Innovative Drugs http://www.tapanray.in/focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs/?utm_source=rss&utm_medium=rss&utm_campaign=focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs http://www.tapanray.in/focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs/#comments Mon, 29 Nov 2021 00:00:53 +0000 Tapan Ray http://www.tapanray.in/?p=10615 Continue reading →]]> http://www.tapanray.in/focus-on-all-3-areas-of-innovation-for-affordable-access-to-innovative-drugs/feed/ 0 Focus More To Create Patient-Perceived Value of Brand Outcomes http://www.tapanray.in/focus-more-to-create-patient-perceived-value-of-brand-outcomes/?utm_source=rss&utm_medium=rss&utm_campaign=focus-more-to-create-patient-perceived-value-of-brand-outcomes http://www.tapanray.in/focus-more-to-create-patient-perceived-value-of-brand-outcomes/#comments Mon, 01 Nov 2021 00:00:27 +0000 Tapan Ray http://www.tapanray.in/?p=10603 Continue reading →]]> http://www.tapanray.in/focus-more-to-create-patient-perceived-value-of-brand-outcomes/feed/ 0 A Game-Changing Non-Covid Drug Approval In the Pandemic Milieu http://www.tapanray.in/a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu/?utm_source=rss&utm_medium=rss&utm_campaign=a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu http://www.tapanray.in/a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu/#comments Mon, 11 Oct 2021 00:00:26 +0000 Tapan Ray http://www.tapanray.in/?p=10595 Continue reading →]]> http://www.tapanray.in/a-game-changing-non-covid-drug-approval-in-the-pandemic-milieu/feed/ 0 What Have And Haven’t Changed In Pharma’s New Normal? http://www.tapanray.in/what-have-and-havent-changed-in-pharmas-new-normal/?utm_source=rss&utm_medium=rss&utm_campaign=what-have-and-havent-changed-in-pharmas-new-normal http://www.tapanray.in/what-have-and-havent-changed-in-pharmas-new-normal/#comments Sun, 26 Sep 2021 00:00:39 +0000 Tapan Ray http://www.tapanray.in/?p=10588 Continue reading →]]> http://www.tapanray.in/what-have-and-havent-changed-in-pharmas-new-normal/feed/ 0